吸引人的花招
发表于 2025-3-25 06:01:43
http://reply.papertrans.cn/47/4621/462064/462064_21.png
真实的人
发表于 2025-3-25 09:19:58
Perspective on Immunotherapy of Colon Cancer: Challenges for the Futurede, with chemotherapy or targeted agents in different molecular subtypes are under evaluation in clinical trials in the attempt to overcome resistance to ICIs in both dMMR/microsatellite unstable and stable tumours.
FLAX
发表于 2025-3-25 11:45:42
http://reply.papertrans.cn/47/4621/462064/462064_23.png
Canary
发表于 2025-3-25 18:01:59
http://reply.papertrans.cn/47/4621/462064/462064_24.png
火车车轮
发表于 2025-3-25 21:32:49
Cameron J. Herting,Gregory B. Lesinskiide these formal organizations. This volume is the first to offer a wide scope of broad variety of forms of civic engagement in contemporary Japan. The volume is quite forceful in counterbalancing oversimplifie978-1-4614-2584-7978-1-4419-1504-7Series ISSN 1568-2579
费解
发表于 2025-3-26 00:29:36
http://reply.papertrans.cn/47/4621/462064/462064_26.png
一个搅动不安
发表于 2025-3-26 05:24:16
http://reply.papertrans.cn/47/4621/462064/462064_27.png
长矛
发表于 2025-3-26 11:35:59
http://reply.papertrans.cn/47/4621/462064/462064_28.png
前奏曲
发表于 2025-3-26 13:29:04
Immunotherapy of Gastric Cancer: Focus on Perioperative Strategiesve setting. This chapter review the current landscape of locally advanced GC treatment, focusing on the role of targeted therapies and immunotherapy, with a special consideration to selected populations of GC (MSI and HER2-positive), and to the immune biomarkers of response.
Genome
发表于 2025-3-26 17:30:08
Immunotherapy in the Treatment of Advanced Colorectal Cancernt. However, at least 96% of metastatic colorectal cancers are pMMR/MSS and do not exhibit responses to treatment with ICIs. Studies are exploring therapeutic combinations with targets such as BRAF, VEGF, and others that may activate T and NK cells, reduce inhibitory signals, and increase robustness of the immune response.